2025-04-01 03:09:27
Latest Post
Infosys and Linux Foundation Networking Collaborate to Strengthen Responsible AI for Global Networks
ITC announces strategic acquisition of Pulp & Paper Undertaking of Aditya Birla Real Estate Limited
AGI Greenpac Ltd approves ~ Rs. 700 crore capex
NHPC Ltd updates on 300 MW Bikaner Solar Power Project
Prashant India Ltd enters into agreement for sale with Shantilon Poly Pvt Ltd
Stock Report
Bliss GVS Pharma Ltd Q3 FY2022-23 consolidated net profit climbs to Rs. 27.94 crores
Posted On : 2023-01-25 16:19:33( TIMEZONE : IST )
Bliss GVS Pharma Limited has reported Consolidated financial results for the period ended December 31, 2022.
Financial Results (Q3 FY2023) - QoQ Comparison
The company has reported total income of Rs. 211.3635 crores during the period ended December 31, 2022 as compared to Rs. 174.5810 crores during the period ended September 30, 2022.
The company has posted net profit / (loss) of Rs. 27.9419 crores for the period ended December 31, 2022 as against net profit / (loss) of Rs. 13.8538 crores for the period ended September 30, 2022.
The company has reported EPS of Rs. 2.64 for the period ended December 31, 2022 as compared to Rs. 1.31 for the period ended September 30, 2022.
| Financials | Q3 FY2023 | Q2 FY2023 | % Change |
| Total Income | ₹211.3635 crs | ₹174.5810 crs |  21.07% |
| Net Profit | ₹27.9419 crs | ₹13.8538 crs | 101.69% |
| EPS | ₹2.64 | ₹1.31 | 101.53% |
Financial Results (Q3 FY2023) - YoY Comparison
The company has reported total income of Rs.211.3635 crores during the period ended December 31, 2022 as compared to Rs.222.2942 crores during the period ended December 31, 2021.
The company has posted net profit / (loss) of Rs.27.9419 crores for the period ended December 31, 2022 as against net profit / (loss) of Rs.-50.1122 crores for the period ended December 31, 2021.
The company has reported EPS of Rs.2.64 for the period ended December 31, 2022 as compared to Rs.-4.74 for the period ended December 31, 2021.
| Financials | Q3 FY2023 | Q3 FY2022 | % Change |
| Total Income | ₹211.3635 crs | ₹222.2942 crs |  -4.92% |
| Net Profit | ₹27.9419 crs | ₹-50.1122 crs | 155.76% |
| EPS | ₹2.64 | ₹-4.74 | 155.70% |
Financial Results (9 Months Ended FY2023) - YoY Comparison
The company has reported total income of Rs.581.6170 crores during the 9 Months period ended December 31, 2022 as compared to Rs.599.6942 crores during the 9 Months period ended December 31, 2021.
The company has posted net profit / (loss) of Rs.67.5150 crores for the 9 Months period ended December 31, 2022 as against net profit / (loss) of Rs.-4.5918 crores for the 9 Months period ended December 31, 2021.
The company has reported EPS of Rs.6.39 for the 9 Months period ended December 31, 2022 as compared to Rs.-0.43 for the 9 Months period ended December 31, 2021.
| Financials | 9 Months Ended FY2023 | 9 Months Ended FY2022 | % Change |
| Total Income | ₹581.6170 crs | ₹599.6942 crs | -3.01% |
| Net Profit | ₹67.5150 crs | ₹-4.5918 crs | 1,570.34% |
| EPS | ₹6.39 | ₹-0.43 | 1,586.05% |
Shares of Bliss GVS Pharma Limited was last trading in BSE at Rs. 71.70 as compared to the previous close of Rs. 71.75. The total number of shares traded during the day was 1434 in over 80 trades.
The stock hit an intraday high of Rs. 72.35 and intraday low of 71.25. The net turnover during the day was Rs. 102945.00.
